Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a research note.
NEW YORK — Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses ...
Compared to its industry, the company has lower Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $3.12 Billion, which is 0.15x below the industry average, potentially ...
Wells Fargo analyst Mohit Bansal maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target ...
Nvidia (NVDA) continues to dominate the tech sector as the company's shares move past $1,100. The chip giant earned a boost ...
After an eventful week compounded by Nvidia's (NVDA) fiscal first-quarter earnings, the major market averages (^DJI, ^IXIC, ...
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from ...